Klaire Labs Melatonin Lozenge Formula Fast Dissolving 1 mg tablets; Packed in a 75 cc HDPE Bottle 60 Tablets UPC: 8 28054 17845 8; SKU: ML1

ProThera, INC. DBA Sfi USA recalled Klaire Labs Melatonin Lozenge Formula in a Class III action, the FDA tier used when a product is unlikely to cause adverse health effects, typically for labeling or minor regulatory issues on Jan 17, 2019.

The FDA-published reason for this recall is: "Small quantity of product labeled as Melatonin Lozenge Formula were filled with L-Theanine."

The product reached multiple states, recorded by the FDA as "One customer in KS." A multi-state footprint means the same lot can surface in households far from the producer. The recalling firm is based in Reno, NV. The recall covers 120 bottles of product. The FDA has Terminated this recall (first reported Mar 6, 2019), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.